Revlimid

Thoughts On The Celgene Revlimid Markman Hearing
Seeking Alpha
Fri, 05/16/14 - 10:21 am
Celgene
Revlimid
Actavis
Celgene: Do The Revlimid Polymorph And Use Patents Matter?
Seeking Alpha
Mon, 05/5/14 - 12:09 pm
Celgene
Revlimid
Celgene Higher on Revlimid Patent Case Document Release
TheStreet.com
Wed, 04/9/14 - 09:35 pm
Celgene
Revlimid
patents
Mylan sues Celgene for blocking Revlimid, Thalomid generics
Yahoo/Reuters
Fri, 04/4/14 - 09:18 am
Celgene
Mylan
Revlimid
generics
Thalomid
Celgene and Pharmacyclics Bring Big Change to Mantle Cell Lymphoma in 2013
Motley Fool
Sat, 12/14/13 - 12:03 pm
Celgene Corporation
Pharmacyclics
mantle cell lymphoma
JNJ
Imbruvica
Revlimid
Celgene advances after analysts say Revlimid data positive
The Fly on the Wall
Mon, 12/9/13 - 11:29 am
Revlimid
Celgene
Multiple Myeloma
Celgene's Revlimid Faces a Tough Sell
Motley Fool
Tue, 11/19/13 - 07:25 am
Celgene
Revlimid
JNJ
Multiple Myeloma
Celgene's Revlimid Makes Stronger Case for European Front-Line Approval
TheStreet.com
Wed, 11/13/13 - 11:00 am
Celgene
Revlimid
Europe
Multiple Myeloma
Celgene: FDA Approvals Shining The Biopharma Stock
Seeking Alpha
Mon, 09/16/13 - 11:48 am
Celgene
FDA
Bristol-Myers Squibb
AbbVie
JNJ
Eli Lilly
Revlimid
Abraxane
Celgene's Multiple Myeloma Powerhouse
Motley Fool
Thu, 08/22/13 - 11:21 am
Multiple Myeloma
Celgene
Thalomid
Revlimid
Pomalyst
3 Biotech Favorites With Noteworthy Drug Data
Motley Fool
Mon, 07/29/13 - 03:05 pm
Alexion
Biogen Idec
Soliris
Celgene
Revlimid
Tecfidera
Celgene halts Revlimid ORIGIN trial due to deaths
Yahoo/Fly on the Wall
Thu, 07/18/13 - 09:50 am
clinical trials
Celgene
Revlimid
chronic lymphocytic leukemia
Celgene Seen Widening Products Beyond Revlimid
Investors.com
Wed, 07/17/13 - 12:40 pm
Celgene
Revlimid
Celgene's Revlimid improves survival in blood cancer patients
Reuters
Thu, 07/11/13 - 11:14 am
Celgene
Revlimid
Multiple Myeloma
Celgene's candidates for non-Hodgkin's lymphomas show positive results
The Fly on the Wall
Thu, 06/20/13 - 12:19 pm
Celgene
non-Hodgkin's lymphoma
Revlimid
rituximab
Celgene's Revlimid wins additional FDA lymphoma approval
Reuters
Wed, 06/5/13 - 05:35 pm
Celgene
Revlimid
FDA
lymphoma
mantle cell lymphoma
Celgene at ASCO: Ho-Hum, Ho-Hum, and Hmmm
Motley Fool
Wed, 06/5/13 - 12:24 pm
Celgene
ASCO
Pomalyst
Abraxane
Revlimid
Celgene's Rich Pipeline Offers Growth
Seeking Alpha
Thu, 04/4/13 - 09:13 am
Celgene
Eli Lilly
Bristol-Myers Squibb
Roche
ONYX Pharmaceuticals
Pomalyst
Revlimid
Abraxane
Celgene's Star Drug Revlimid And Its Competitors
Seeking Alpha
Sat, 03/30/13 - 10:57 am
Celgene
Revlimid
Multiple Myeloma
JNJ
Velcade
AbbVie
Bristol-Myers Squibb
elotuzumab
Can Johnson & Johnson Hold Its Ground in the Multiple Myeloma Market?
Motley Fool
Wed, 02/13/13 - 10:16 am
JNJ
Multiple Myeloma
Velcade
Celgene
Revlimid
AbbVie
ONYX Pharmaceuticals
Bristol-Myers Squibb

Pages